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The role of osteopontin in children with systemic inflammatory response 
syndrome and sepsis 
 
INTRODUCTION 
Sepsis is a leading cause of morbidity and mortality 
in critically ill children despite the use of modern 
antibiotics and resuscitation therapies.1 Sepsis was 
defined as the presence of the symptoms and signs 
of systemic inflammatory response syndrome 
(SIRS) associated with infection. Sepsis must be 
distinguished from non-infection SIRS induced by 
agents such as trauma and ischemia causing 
extensive tissue injury to establish appropriate 
treatments in critically ill patients, since therapies 
and outcomes greatly vary in patients with and 
without infection.2 Recent attention has been 
directed towards the study of the role of cytokines 
e.g. tumor necrosis factor- alpha (TNF-α), 
interleukin-1β (IL-1β), and interleukin -6 (IL-6) in 
the regulation of inflammation and host responses 
to infection.3 Osteopontin is a phosphoprotein with 
adhesive and cell signaling function; it can act 
either as an extracellular matrix component in 
mineralized tissue or as a soluble cytokine in 
inflamed tissue and serum.4 During inflammation, 
osteopontin is expressed by macrophages and T 
lymphocytes.5 It acts as a pro-inflammatory 
cytokine by chemoattracting monocyte, 
macrophage and lymphocyte. Also it modulates T 
cell function by affecting the differentiation of T 
lymphocytes into Th1 and Th 2 cells, regulating the 
balance between Th1 and Th 2 and participating in 
the cell induced immunological response. At the 
same time, osteopontin stimulates B lymphocytes to 
express multi-clone antibodies. 6 Moreover it plays 
a role in the protection against herpes virus and 
bacterial infections through the activation of the 
Th1 response and induction of Th1 cell-mediated 
immunity.7 Interleukin -6 (IL-6) is produced mainly 
by T cells, macrophages and endothelial cells. IL-6 
induces the synthesis of acute phase proteins in the 
liver and stimulates the production of neutrophils. It 
Original article 
Introduction: Sepsis is a leading cause of morbidity and mortality in 
critically ill children despite the use of modern antibiotics and resuscitation 
therapies. Sepsis must be distinguished from non-infection systemic 
inflammatory response syndrome (SIRS) induced by agents such as trauma 
and ischemia causing extensive tissue injury to establish appropriate 
treatments in critically ill patients. Osteopontin acts as an extracellular 
matrix component or soluble cytokine in inflamed tissues. Its exact role in 
immune response and sepsis remains to be elucidated. Objective: This study 
investigated the level of osteopontin in SIRS and sepsis to assess its 
involvement in the acute inflammatory diseases and its possible role as a 
marker differentiating children with SIRS from those with sepsis.  Methods: 
Prospective, observational study at pediatric ICU at the children’s Hospital, 
Zagazig University, Egypt, from October 2013 to December 2014. Forty-
four patients with SIRS or sepsis and 44 healthy subjects were enrolled. All 
the children were subjected to detailed medical history, Clinical 
examination, laboratory estimation for CBC, blood cultures, serum 
osteopontin and IL-6 determination was performed by sandwich enzyme 
immunoassay technique. Results: Serum osteopontin levels were 
significantly higher in patients than in controls and in sepsis than in SIRS, 
and decreased during the resolution of both the disorders. A receiver 
operating characteristic curve identified that osteopontin level of 1040 ng/ml 
has discriminative power between SIRS and sepsis patients with 82.6% 
sensitivity and 70.4% specificity, area under curve was 0.833. Osteopontin 
levels directly correlated interleukin-6 levels and clinical severity scores. 
Conclusion: Osteopontin is strongly up-regulated during SIRS and sepsis 
and correlate with IL6 and clinical severity scores. 
 
Key Words: Sepsis, Inflammation, Osteopontin, IL-6, Cytokines. 
Mohamed A. Talat, 




Pediatrics and Clinical 

















Mohamed A. Talat, 
Lecturer of pediatrics, 
Faculty of Medicine, 
Zagazig University, 
Zagazig, Egypt.  
E-mail: abo.talat@ 
yahoo.com 
Talat and ElSaid. 
66 
also stimulates growth and proliferation of B 
lymphocytes.8 
This study investigated the level of osteopontin 
in SIRS and sepsis to assess its involvement in the 
acute inflammatory diseases and its possible role as 
a marker differentiating children with SIRS from 




This prospective observational study was performed 
on 88 children, 44 children were patients group 
with SIRS or sepsis (31 males and 13 females). 
Their ages ranged between 3 month and 10 years of 
age. These patients were admitted to the pediatric 
ICU at the Children’s Hospital, Zagazig University, 
Egypt, from October 2013 to December 2014.The 
study was approved by the Institutional Ethical 
Committee of Zagazig University; written informed 
consent was obtained from the parents of the 
patients involved in the study as recommended by 
the ethics committee and in accordance with the 
Helsinki declaration.   
Patients were enrolled when they met the criteria 
of SIRS or severe sepsis and septic shock (SS/SS).2 
Diagnosis of SIRS was made based on the presence 
of two or more of the following criteria (1) 
temperature (core or rectal) >38.50C or <35.50C. (2) 
tachypnea (respiratory rate >95 percentile for age 
breaths/min or PaCO2 <32 mmHg) (3) tachycardia 
(heart rate >95 percentile for age beats/min) (4) 
white blood cells count >12,000 or 
<4,000cells/mm3 or the presence of more than 10% 
immature neutrophils (band cells). Patients had 
sepsis when they developed SIRS as a result of 
infection which was proved clinically and by blood 
culture.2 Septic patients with organ dysfunction 
were considered to have severe sepsis and those 
with persisting hypotension, requiring vasopressor 
treatment were considered to have septic shock.9 
Pediatric risk of mortality (PRISM) scores were 
calculated for all patients at admission and the 
Sequential Organ Failure Assessment(SOFA) 
scores were conducted by physicians blinded to the 
experimental results to assess the clinical severity 
and progression of the cases.10,11  
The two groups consisted of 21 patients with 
SIRS and 23 with SS/SS. We also studied; (1) 44 
healthy children (29 males and 15 females) defined 
as controls, matched for gender and age. (2) 17 
patients in resolution from SIRS (10 patients) and 
SS/SS (7 patients).The resolution group comprised 
patients who no longer met the inclusion criteria of 
SIRS. 
Children were excluded if they had chronic 
systemic inflammatory disease, primary or acquired 
immunodeficiency diseases, were on corticosteroids 
or nonsteroidal anti-inflammatory drugs. 
   
Sample collection 
All blood samples were obtained within 6 hours of 
meeting the criteria of SIRS.2 For patients analyzed 
during the resolution phase, blood withdrawal was 
performed on the first day in which they lost the 
inclusion criteria.  
All patients were subjected to the following 
laboratory  investigations; complete blood pictures 
(CBC) were performed on Sysmex-Kx-21 (Sysmex 
corporation–Japan), C-reactive protein (CRP), liver 
function tests were done on Cobas 6000 (Roche 
diagnostics-Switzerland) and blood cultures were  
done on Bact Alert analyser and organism 
identification were done by the Vitek MS system 
(bioMe ŕieux).  
Osteopontin and Interleukin -6 were measured 
using a sandwich enzyme immunoassay technique, 
Osteopontin (ELISA kit) provided by (Glory 
Science Co., Ltd, USA), IL-6 assayed by Assay 
Max Human Interleukin-6 ELISA Kit (catalog 
Number EI1006-1). Blood samples were collected 
from all subjects into vacutanier tubes and 
centrifuged at 2500 g for 15 minutes then the sera 
were stored at -80OC until assay according to 
manufacturer’s instructions. The lowest sensitivity 
limits for the detection was 2 ng/ml for osteopontin 
and 10 pg/ml for IL-6. 
 
Statistical methods 
Mann–Whitney U-test and Wilcoxon’s signed rank 
were used to analyze the unpaired and paired data 
respectively. Comparison between groups was 
performed using Kruskal–Wallis test. Correlations 
were tested with Spearman’s coefficient. A p value 
<0.05 was considered statistically significant. Data 
were analyzed by sensitivity (percent of positives 
detected correctly identified) and specificity 
(percent of negatives detected correctly identified) 
and area under the curve (AUC) derived from the 
receiver operating characteristic curve (ROC).12 
Statistical analysis was performed SPSS (Statistical 
package for social sciences) version 19.  
 
RESULTS 
We studied 21 patients with SIRS and 23 with 
SS/SS the pediatric ICU at the Children’s Hospital, 
Zagazig University, Egypt, and 44 healthy matched 
for gender and age, as controls. Moreover 17 
patients were also analyzed on the first day in 
which they lost the inclusion for SIRS. Baseline 
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clinical features of the patients are summarized in 
Table 1. Clinical severity was evaluated using 
Pediatric risk of mortality (PRISM) scores and the 
Sequential Organ Failure Assessment(SOFA) 
scores .Both scores were significantly different in 
SS/SS and SIRS patients(p< 0.001).  
Regarding microbiological finding, the primary 
focus of infection in the patients with SS/SS was 
the lung in 12 (52.2%), central nervous system in 5 
(21.7%), intestine in 4 (17.4%) and blood in 2 
(8.7%). It was possible to isolate microorganisms in 
the blood of 23 patients with SS/SS. In 14 (60.9%) 
patients, gram-negative organisms were identified, 
in 7 (30.4%) cases there were gram-positive and in 
another two (8.7%) patients the infection was 
polymicrobial.    
Serum osteopontin levels were strikingly higher 
in patients than in the controls. Moreover, they 
were significantly higher in SS/SS than in SIRS) 
and seems to be associated with the clinical 
outcome as they were significantly higher in non-
survivors than in survivors as revealed in Table 2  
and displayed a direct correlation with clinical 
severity scores (PRISM: r = 0.684,  p< 0.001 ; 
SOFA: r =0.677, p < 0.001). Furthermore, during 
the resolution phase osteopontin levels markedly 
decreased (median 420 ng/ml) compared to the 
acute phase of the disease (median 1004 ng/ml, 
p<0.001), but still threefold higher than controls 
(Fig.1).  
IL6 levels were higher in patients than in the 
controls .Also IL6 levels were significantly higher 
in SS/SS than in SIRS. IL-6 levels were higher in 
non-survivors than in survivors, but without 
statistical significance as revealed in Table 2. 
Osteopontin levels displayed a significant direct 
correlation with IL-6 (r =0.506, p< 0.001) as seen 
Fig.2. IL-6 levels decreased during the resolution 
phase (median 38 pg/ml) compared to the acute 
phase of the disease (median 70 pg/ml, p<0.001), 
but still higher than controls (Fig.1).      
In the view of the significant difference of 
osteopontin and IL-6 levels in patients with severe 
sepsis/septic shock (SS/SS) and those with SIRS, 
we use the receiver operator characteristics curve 
(ROC) to explore their ability to differentiate SS/SS 
and SIRS patients. The area under the curve (AUC) 
was 0.833 (95% CI 0.713-0.954, P < 0.001) for 
osteopontin and 0.717 for IL-6 (95% CI 0.567-
0.868, P = 0.014). For osteopontin, the optimal cut- 
off value discriminating between SS/SS and SIRS 
was 1044 ng/ml and gave a sensitivity of 82.6% and 
specificity of 70.4% with a positive likelihood ratio 
of 2.88 and for IL-6 optimal at cut- off value was 
87 pg/ml and gave a sensitivity of 73.9% and 
specificity of 66.7% with a positive likelihood ratio 














25±14.3 27.3±15.33 24.6±14.9 26.2±16 Age in months Mean±SD 
29/15 12/5 16/7 15/6 M/Fa 
- 8(4-12) 22(18-30) 11(6-16) c PRISMb 
- 4(3-7) 12(10-16) 5(3-8)c  SOFAb 
- 0 7(34.7%) 3(14.2%) ICU mortality 
Results are shown as absolute numbers, proportions are in bracketsa 
Results are shown as median, interquartile ranges are shown in bracketsb 
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Table 2. Levels of osteopontin and interleukin -6 





























































Figure 1. Serum osteopontin and interleukin-6 in acute phase of the disease and in resolution phase, 





Figure 2. Significant direct correlation between serum osteopontin and interleukin-6 in patients with SIRS 
and severe sepsis / septic shock (r =0.506, p< 0.001) 
 




Figure 3. Receiver operator characteristic curve (ROC) evaluating the accuracy of osteopontin and IL-6 to 
differentiate SS/SS and SIRS patients. A ROC curve identified that a osteopontin level (cut-off value) 1040 
ng/ml has discriminative power between SIRS and sepsis patients with 82.6% sensitivity and 70.4% 
specificity, area under curve was 0.833 (95% CI 0.713 -0.954, P < 0.001) and while IL6 level (cut-off value) 
87 pg/ml has discriminative power with sensitivity of 73.9% and specificity of 66.7%, area under curve was 
0.717 for IL6 (95% CI 0.567 -0.868, P = 0.014). 
 
                   
DISCUSSION 
Sepsis biomarkers can indicate the presence or 
absence or severity of sepsis and can differentiate 
bacterial from viral or fungal infection and systemic 
sepsis from local infection. Other potential uses of 
biomarkers include roles in prognosis, guiding 
antibiotic therapy, evaluating the response to 
therapy and recovery from sepsis, differentiating 
Gram-positive from Gram-negative microorganisms 
as the cause of sepsis, predicting sepsis 
complications and the development of organ 
dysfunction (heart, kidneys, liver or multiple organ 
dysfunction).3 Osteopontin is implicated in several 
events, including cell mediated immunity, cell 
survival and tumor progression. Its vital role in both 
acute and chronic inflammation is now obvious.5,6 
Its role in inflammatory process through 
interactions with several integrins, also it  mediates 
cell migration, adhesion and survival in many cell 
types. Osteopontin encourage Th1 cell-mediated 
immunity, promotes cell-mediated immune 
responses.13,14  
Because of the better sensitivity and specificity, 
procalcitonin, CRP and IL-6 are commonly used as 
biomarkers in the diagnosis, while assessing the 
severity of infection and guiding the use of 
antibiotics. But meta-analysis found that the 
sensitivity and specificity procalcitonin and CRP 
varied in the diagnosis of sepsis. 
The sensitivity of IL-6 was not high and 
declined gradually as the time of infection 
extended. These findings questioned their ability to 
distinguish sepsis from SIRS.15      
Many studies have reported increased 
osteopontin levels in chronic inflammatory disease 
such as systemic lupus erythematosus16 and Crohn’s 
disease.17 Fewer studies focus on acute 
inflammatory diseases in pediatric. In all these 
inflammatory diseases, osteopontin levels seem to 
be a good marker of the host response, since they 
increased with the severity of the disease. In this 
study, we found that serum osteopontin levels were 
markedly higher in patients with SIRS or SS/SS 
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in SIRS and decreased with the resolution of both 
conditions. 
Osteopontin levels could be used to discriminate 
between SIRS and sepsis as most septic patients 
(15/23, 65.2%) displayed higher osteopontin levels 
than the 75th percentile limits displayed by patients 
with SIRS (1148 ng/ml).Also the diagnostic 
accuracy of osteopontin in discriminating SIRS 
from sepsis, as evaluated from the ROC curve ,was 
near to that reported in recent meta-analysis for 
procalcitonin18,19,i.e the main serum protein markers 
currently used to monitor systemic inflammation.     
IL6 is believed to play a key role in sepsis asIL-
6 enhances B cell differentiation into mature plasma 
cells and secretion of immunoglobulins and shares 
several activities with Interleukin-1 (IL-1), 
including production of acute phase proteins 
(APPs) and induction of pyrexia. IL-6 is the most 
important inducer of hepatocyte synthesis of APPs). 
IL-6 levels are significantly elevated during sepsis, 
and this precedes the appearance of other cytokines. 
IL-6 has a short half-life, and its sensitivity 
decreases after 12 to 24 hours. IL-6 as a marker in 
the early phases of infection has been evaluated in 
many studies.20,21 
In this study, we found that serum IL6 levels 
were markedly higher in patients with SIRS or 
SS/SS than in controls.they were also higher in 
SS/SS than in SIRS, and decreased with the 
resolution of both conditions. However it seem no 
better than procalcitonin in the diagnosis of sepsis 
as it displays lower sensitivity and specificity.19                                    
The direct correlation between the serum 
osteopontin and IL-6 levels in SIRS and SS/SS 
suggest that these cytokines may be functionally 
related, as their secretion may be coordinated by the 
responsiveness to the same stimuli, especially since 
the osteopontin and IL-6 genes share 
responsiveness to the transcription factor NF-IL6 
involved in the acute phase response and 
macrophage activation.20 However a study done on 
adult patients by Vaschetto et al.,22 suggest that 
osteopontin may also directly promote IL-6 
secretion, since recombinant osteopontin (rOPN) 
induced mRNA expression and stimulated IL6 
secretion by monocytes. 
Our study reveal that osteopontin display more 
sensitivity and specificity than IL6 in the diagnosis 
of sepsis (82.6% and 70.4% for osteopontin at S 
value (1044 ng/ml) and 73.9% and 66.7% ) for IL6 
at s value (87 pg/ml). This result are in agreement 
with Vaschetto et al.,22 who found osteopontin has 
sensitivity and specificity (70% and 79% for 
osteopontin but at a higher s value (1708 ng/ml) 
more than IL-6 in the diagnosis of sepsis in adult 
patients. So osteopontin levels could supplement 
the data given by IL-6 in the diagnosis of sepsis. 
The data also showed that osteopontin but not IL6 
levels displayed a direct correlation with clinical 
severity scores (PRISM and SOFA) and seems to 
be more associated with the clinical outcome of the 
disease. 
In conclusion, serum osteopontin levels are 
higher in SIRS and SS/SS than controls and the 
high osteopontin levels could be discriminate 
between SIRS and SS/SS. Osteopontin levels 
correlate with IL-6 levels and clinical severity 
scores (PRISM and SOFA). 
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